Year: 2024

StickIt Technologies Inc. Announces a ground-breaking new development of a medical straw for delivering vitamins to children and adults for 2025

VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- StickIt Technologies Inc. (the" Company "or "StickIt") (CSE: STKT), an Israeli Canadian technology...

Longevity and Caregiving Conference Gathers Key Thought Leaders in Nation’s Capital to Discuss Transformational Changes for the $648B Care Economy

WASHINGTON, Dec. 9, 2024 /PRNewswire/ -- Thought leaders in longevity and caregiving will convene at the National Press Club here December...

Hot Topics in Neonatology® 2024 Conference to Feature Symposium on Clinical Impact & Cost Savings of an Exclusive Human Milk Diet

Dr. Jenny Fox From Children's Hospital of Richmond at Virginia Commonwealth University to Present Published Data and Firsthand Insights on...

Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company

Clinician-trained AI analyzes electronic records to match ideal patients with studies in seconds rather than hours, optimizing research and reducing...

Study Results from COTA, PreciseDx, and Baptist Health South Florida Confirm Novel AI Test, PreciseBreast is Equivalent to Oncotype DX at Predicting Breast Cancer Recurrence

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

error: Content is protected !!